The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy
BACKGROUND: Adalimumab is a fully humanized monoclonal antibody inhibitor of tumor necrosis factor-a used to treat various autoimmune disorders. Adalimumab poses a risk for tuberculosis (TB) infection, especially in countries where TB is endemic. OBJECTIVE: Determine the rate of TB infection after a...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
King Faisal Specialist Hospital and Research Centre
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/509a4578978a4742b75b0e1ee2ff05a3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|